Cefzlora 100 Dry Syrup contains Cefixime 100mg/5ml, a third-generation cephalosporin antibiotic indicated for the treatment of pediatric bacterial infections. It helps manage infections of the respiratory tract, ENT, urinary tract, and skin, providing effective relief and recovery in children.
Cefixime works by inhibiting bacterial cell wall synthesis, leading to elimination of susceptible bacteria. Its broad-spectrum activity and palatable dry syrup formulation ensure accurate pediatric dosing and high compliance.
This formulation is recommended by pediatricians for mild to moderate bacterial infections and ensures precise, reliable dosing. Cefzlora 100 Dry Syrup is a high-demand pediatric antibiotic across hospitals, clinics, and public health programs.
Adding Cefzlora 100 Dry Syrup to your pediatric antibiotic segment strengthens your portfolio with a trusted cephalosporin therapy. Its prescriber preference, consistent demand, and applicability for domestic and export markets make it a valuable addition to pharmaceutical distribution portfolios.